Aflac Incorporated (NYSE:AFL) Shares Sold by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 16.6% during the 3rd quarter, Holdings Channel.com reports. The fund owned 15,227 shares of the financial services provider’s stock after selling 3,022 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Aflac were worth $1,702,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of AFL. Y.D. More Investments Ltd acquired a new stake in shares of Aflac during the 2nd quarter worth approximately $25,000. Dixon Mitchell Investment Counsel Inc. bought a new position in Aflac during the 1st quarter worth $34,000. Cedar Wealth Management LLC acquired a new stake in Aflac in the first quarter worth $50,000. Fairscale Capital LLC acquired a new stake in Aflac in the second quarter worth $54,000. Finally, HHM Wealth Advisors LLC lifted its stake in Aflac by 178.6% in the second quarter. HHM Wealth Advisors LLC now owns 624 shares of the financial services provider’s stock valued at $56,000 after buying an additional 400 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

Shares of Aflac stock opened at $109.69 on Friday. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. The company’s 50-day moving average price is $110.22 and its two-hundred day moving average price is $96.59. The stock has a market cap of $62.33 billion, a PE ratio of 12.11, a price-to-earnings-growth ratio of 2.62 and a beta of 0.95.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.60 by $0.23. The business had revenue of $5.14 billion during the quarter, compared to analyst estimates of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business’s quarterly revenue was down .7% on a year-over-year basis. During the same period in the prior year, the business earned $1.58 earnings per share. As a group, sell-side analysts anticipate that Aflac Incorporated will post 6.76 EPS for the current fiscal year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date was Wednesday, August 21st. Aflac’s dividend payout ratio is presently 22.08%.

Analyst Upgrades and Downgrades

AFL has been the topic of a number of analyst reports. Citigroup increased their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. JPMorgan Chase & Co. lifted their price target on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. Barclays initiated coverage on Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective for the company. Bank of America lifted their target price on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Finally, Truist Financial increased their price target on Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Aflac presently has an average rating of “Hold” and a consensus target price of $97.53.

Insider Buying and Selling

In other news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.